Blue Earth Diagnostics and Northern California PET Imaging Center Announce Region’s First Commercial AxuminTM (Fluciclovine F 18) Administration

Blue Earth Diagnostics and Northern California PET Imaging Center Announce Region’s First Commercial AxuminTM (Fluciclovine F 18) Administration

“We are committed to providing cutting-edge molecular imaging to help improve the quality of patient care,” said Steven Falen, M.D., Ph.D., Medical Director of Northern California PET Imaging Center. “Axumin is a new PET imaging agent to help identify sites of disease in biochemically recurrent prostate cancer patients.

Read the full Press Release or FAQ

This entry was posted on May 15, 2017